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Abstract  
Removal of nine pharmaceutical compounds: acetaminophen, AAF, antipyrine, 
ANT, caffeine, CAF, carbamazepine, CRB, diclofenac, DCF, hydrochlorothiazide,  
HCT, ketorolac, KET, metoprolol, MET and sulfamethoxazole, SMX, spiked in a 
primary sedimentation effluent of a municipal wastewater has been studied with  
sequential aerobic biological and ozone advanced oxidation systems. Ozone, UVA 
black light and Fe(III) or Fe3O4 constituted the chemical systems. During the 
biological treatment, only AAF and CAF were completely eliminated, MET, SMX 
and HCT reached partial removal rates and the rest of compounds were completely 
refractory (HRT=24 h). With any ozone advanced oxidation process applied, the 
remaining pharmaceuticals disappear in less than 10 minutes. The presence of Fe3O4 
or Fe(III) during photocatalytic ozonations also allowed mineralization increases, 
compared to the single ozonation process, from 13% to about 35%. Biodegradability 
of the treated wastewater increased 50% in the biological process and other 150% 
after the ozonation processes. Both untreated and treated wastewater was non toxic 
for Daphnia Magna except when Fe(III) was used in photocatalytic ozonation. In 
this case, the ferryoxalate formed seems to be the reason of toxicity. Kinetic 
information on ozone processes reveals that pharmaceuticals at the very low 
concentrations they are found in urban wastewater are mainly removed through free 
radical oxidation.  
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1. Introduction 
 
Now days the presence of pharmaceuticals and their metabolites in urban 
wastewater, mainly as a consequence of the uptake of medicines, is largely known 
[1-5]. Because of the presence of active biochemical principles in their molecules, 
pharmaceuticals, once released to water environments, present potential hazardous 
effects on humans and aquatic ecosystems [6,7]. Removal of these contaminants 
should be achieved in conventional wastewater treatment plants, mainly through 
biological oxidation, but these systems are not specifically designed for this role. In 
fact, as rule of thumb, emerging contaminants pass unaffected in a great extent 
through the classical unit operations of wastewater treatment plants [8-11]. However, 
because of their persistent and potentially hazardous character, these compounds 
may negatively affect living organisms in the aquatic environment and, 
consequently, more advanced treatments are needed to complete their removal from 
wastewater. In this sense, several researches have shown that ozonation and 
advanced oxidation processes (AOPs) have been successfully used to oxidize these 
contaminants from water [12-14]. Thus, literature has already reported many works 
where laboratory prepared aqueous solutions or biologically treated urban 
wastewater spiked with emerging contaminants (ECs) are successfully treated with 
AOPs. However, results on the combined effect of biological and advanced 
oxidation processes are required in order to check the real improvement in removal 
rates when these contaminants are initially present in the wastewater. Thus, in this 
work, an urban wastewater doped with nine ECs has been biologically and 
chemically treated in two sequential steps with activated sludge and different AOPs, 
respectively. Activated sludge was collected from a secondary biological treatment 
of an urban wastewater treatment plant and ozone, UVA light and iron type catalysts 
(Fe(III) and Fe3O4) were the constituents agents of AOPs applied. The ECs added to 
the wastewater were acetaminophen (AAF), antipyrine (ANT), caffeine (CAF), 
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carbamazepine (CRB), diclofenac (DCF), hydrochlorothiazide (HCT), ketorolac 
(KET), metoprolol (MET) and sulfamethoxazole (SMX). These compounds are very 
used both for medical or social purposes and are commonly identified in urban 
wastewaters [15-17]. 
 
2. Materials and methods 
 
2.1. Primary wastewater effluent and chemicals 
 
Wastewater from the first sedimentation unit or primary treatment effluent of the 
Rincón de Caya Wastewater Treatment Plant (WWTP) (Badajoz, Spain) was spiked 
with the nine selected pharmaceuticals with an initial concentration of 200 µg L
-1
 
each one. This concentration, although something higher than the actual ones 
encountered in urban wastewater, that usually reach as much as some µg L
-1
 [12,18]  
allowed a more accurate and fast quantitative chemical analysis with our available 
equipments (see below). The physico-chemical characterization of the wastewater 
used is summarized in Table 1. Pharmaceuticals and Fe(ClO4)3.xH2O were 
purchased from Sigma-Aldrich (Spain), and Fe3O4 from Bendix. Other chemicals 
were at least reagent grade and used as received.  
The molecular structures of pharmaceuticals used are shown in Figure 1. These 
contaminants were chosen because they were of different families of pharmaceutical 
compounds: analgesic, beta-blockers, antiepileptic, antibiotic, etc, and are usually 
detected in urban wastewater [15-17]. 
 
2.2. Activated sludge 
 
Aerobic biological treatment was carried out using activated sludge as biomass. This 
biomass was collected from the returning pipe of the activated sludge in Rincón de 
Caya WWTP (Badajoz, Spain).  
 
2.3. Experimental Setup 
 
2.3.1. Biological Treatment 
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Aerobic biological oxidation experiments were carried out in batch mode in a 30 L 
parallelepiped tank provided with mechanical stirring and aerated through several 
diffusers to reach 3.0 mg O2 L
-1
 (see Figure 2). The reactor was charged with the 
primary effluent from the urban WWTP spiked with pharmaceuticals mixtures. The 
activated sludge added varied between 1 and 3 mg L
-1
 of Mixed Liquor Volatile 
Suspended Solids (MLVSS). Hydraulic retention time was between 7 and 24 h. 
Steadily, samples were withdrawn from the reactor and analyzed for contaminant 
concentrations, total organic carbon (TOC), chemical oxygen demand (COD) and 
ultraviolet absorbance at 254 nm (Abs254). Also, biochemical oxygen demand after 
five days (BOD5) was measured at the start and end of experiments. In some 
experiments, the ecotoxicity to Daphnia magna was also determined. Prior to the 
analysis, the solid was removed from samples by a 5415D Eppendorf Centrifuge 
(Hamburg, Germany) and further filtration through a Millex HV filter (Millipore, 22 
μm). 
 
2.3.2. Advanced Oxidation Processes 
Experiments were carried out in semibatch mode in a 1 L cylindrical borosilicate 
glass reactor that was provided with gas inlet (through a diffuser placed at the bottom 
of the reactor) and outlet, mechanical stirring and sampling port (see Figure 3). 
Ozonation experiments were carried out with an ozone-oxygen gas mixture flow of 
35 L h
-1
. Ozone was produced from pure oxygen with a Sander Laboratory Ozone 
Generator.  In experiments requiring UVA light, the aqueous solution was irradiated 
with two 15 W tubular black light (BL) lamps (HQ Power Lamp 15TBL) emitting 
mainly 365 nm radiation. The lamps were installed on opposing walls outside the 
reactor in a closed box. The reactor walls were covered by aluminium foil to enhance 
radiation. Ferrioxalate actinometry was used to determine the incident flux of 
radiation that was found to be 7.05 ± 0.05  10-5 Einstein min-1  
During each experiment, samples were withdrawn from the reactor to analyze 
pharmaceuticals and oxalic acid concentration, TOC, COD, initial and final BOD5, 
Abs254, total iron concentration and dissolved ozone concentration.  
 
2.4. Analytical methods 
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High performance liquid chromatography (HPLC) was applied using LaChrom Elite 
equipment (Hitachi, Spain) to determine the pharmaceuticals concentrations in 
samples. HPLC was provided with a Phenomenex (Spain) Synergi Hydro-RP 
column (250 × 4.60 mm, particle size 4 m, 80 Å), an L-2450 DA detector and EZ 
Chrom software for data treatment. The injection volume was 99 L. The mobile 
phase used in the chromatographic separation consisted of a binary mixture of 
solvents A (Acetonitrile) and B (acidified water with 0.1% formic acid). A non-
isocratic mobile phase gradient program was used: it consisted of 40 min linear 
gradient from 10% to 100% of A with a flow rate of 0.2 mL min
-1
. The separation 
was monitored at different absorbance wavelength as shown in Table 2. Detection 
limit for accurate measurements of concentrations was about 2 µg L
-1
. From standard 
solutions, the analysis was repeated to establish the precision of the method that 
resulted to be 2% while accuracy was 1.3%. 
For oxalic acid concentration, a Supelcogel C-610 column was used. In this case, the 
mobile phase, at a flow rate of 0.75 mL min
-1
, was ultrapure water acidified at pH 
2.5 with phosphoric acid (0.1% concentration). Detection was made with an L-2455 
Hitachi Diode Array detector at 210 nm and injection volume was 40 µL. 
TOC was determined by a TOC-VCSH Shimadzu Analyzer (VWR, Spain). In this 
case, detection limit, precision and accuracy were 50 µg L
-1
, 3% and 1.5% according 
to Shimadzu manufacturer, respectively. COD was measured following standard 
dichromate reflux method in a Dr. Lange spectrophotometer [19] (Precision: 3%). 
BOD was measured following the respirometric method [20] (Precision: 15%). Total 
iron concentration was determined by the ferrozine method [21] that, briefly, 
consisted in the reduction to Fe(II) and further formation of a violet complex with 
the ferrozine reagent. Finally, for the ozonation runs, dissolved ozone concentration 
in aqueous solutions was analyzed by the indigo method [22]. According to the 
authors this method presents 2% precision and a detection limit of 10
-7
 M for 
absorbance measurements in 5 cm cell. In this work, 1 cm cell was used so that 
detection limit was 5x10
-7
 M. Ozone in the gas phase was monitored by means of an 
Anseros Ozomat ozone analyser. The pH was tested with a pH meter (Crison GLP-
21+). Prior to the analysis, the solid was removed from samples by filtration through 
a Millex-HV filter (Millipore, 0.22 μm). 
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2.5. Test organisms 
 
Daphnia magna are freshwater invertebrates of the order Cladocera, more commonly 
known as the water flea. They have a relatively short life (7-8 weeks at 20 ºC) and 
reach sexual maturity within 6-8 d of leaving the brood chamber [23]. Due to their 
size, ease of culture and short life span, D. magna are extensively used as a 
representative freshwater invertebrate species in ecotoxicological studies. 
 
2.5.1. Daphnia acute immobilisation test 
Acute toxicity Daphnia tests were conducted following the commercial test kit 
DAPHTOXKIT F
TM 
(Creasel BVBA; Deinze, Belgium) using the water flea D. 
magna. These tests were performed in accordance with testing conditions prescribed 
by OECD Guideline 202 [24] (Daphnia sp. Acute Immobilisation Test). 
Experiments were run at temperatures of 20±2 ºC and 6000 lux. Twenty daphnids 
younger than 24 h were used for the controls and each assayed solution subdivided in 
four replicates each containing five daphnids. Immobility was observed after 24 and 
48 h with the latter being the endpoint for effect calculation. A Daphnia was 
considered to be immobile if it did not move after 15 s of gentle agitation. 
Immobilisation of the animals leads to their death because of inherent impossibility 
of capturing food.  
A limit test was performed with the solutions in order to demonstrate that the EC50 
(EC50 is the concentration estimated to immobilise 50 per cent of the daphnids within 
a stated exposure period) is greater than the concentration sampled. When the 
percentage of immobilisation is minor or equal 10 % at the end of the test (48 h), it 
can be considered that solution does not show acute toxicity to D. magna. Potassium 
dichromate (K2Cr2O7) was the reference chemical used. 
 
3. Results and Discussion 
 
3.1. Biological treatment 
 
First, a series of biological experiments were carried out. As an example of the 
results obtained, Figure 4 shows the changes with time (up to 24 hours) of the 
remaining dimensionless concentration of the selected pharmaceuticals. As it can be 
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seen, only three compounds: AAF, CAF and MET showed significant removal rates. 
In fact the first two are completely removed in less than 10 hours. The rest of 
compounds were completely refractory to biological oxidation, except SMX and 
HCT that presented less than 25% and 15% conversions in 24 hours treatment.  
It should be noted, that in this work no attempt was made to elucidate the mechanism 
of removal during biological oxidation since two possible ways can develop: 
biological oxidation itself and adsorption on activated sludge. The objective was 
only to check the order of removal to be compared to the further chemical oxidation 
process. In any case, it can be highlighted that previous works report adsorption as 
the main way of pharmaceutical removal from urban wastewater [25-30]. In Figure 
5, on the other hand, the changes observed on TOC with time corresponding to the 
experiment of Figure 4 are presented. Results of COD with time showed a similar 
trend. In this case, there is a deep decrease of COD after about the first 2 hours of 
treatment. After this reaction time, COD was practically unaffected. Regarding TOC 
evolution (see Figure 5), this parameter reduces to reach a conversion of about 55% 
during the first 10 hours of treatment and then slowly reaches 60% elimination after 
24 hours. 
The effect of activated sludge concentration was also studied. However, in this case, 
changes of initial MLVSS loading did not lead to any significant variation of the 
remaining concentration of pharmaceuticals studied and COD and TOC (results not 
shown). 
 
3.2. Advanced oxidation processes  
 
In a second series of experiments, advanced oxidation processes were applied to the 
biologically treated urban wastewater. For these cases, 7 hours laboratory 
biologically treated wastewater was subsequently subjected to advanced chemical 
oxidation technologies. This was due to the fact that the wastewater treatment plant 
of Badajoz has a 7 hour hydraulic residence time (HRT) for the biological operation. 
Then, in these samples concentration of pharmaceuticals was the one they had at the 
end of the laboratory biological process. Thus, the biologically treated wastewater 
only had 7 out of 9 initial pharmaceuticals. The oxidation processes applied were 
ozonation, photocatalytic oxidation and photocatalytic ozonation. Also, direct 
photolysis experiments were carried out for comparative reasons. Two iron catalysts 
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were used, Fe(III) and magnetite (Fe3O4). Photolysis of these iron catalysts leads to 
hydroxyl radicals as has been shown in previous works [31,32]. As expected, direct 
photolysis of any of the 7 remaining compounds did not lead to positive results since 
these compounds do not absorb radiation in the wavelength emitted by the UVA 
lamp used in this work. Also, photocatalytic oxidation with the iron catalysts used 
did not either lead to any pharmaceutical degradation As shown in Figure 6, as 
example, ozone processes were the only ones among those studied here that 
effectively allowed significant or even total elimination of the pharmaceuticals 
studied. This, on the other hand, confirmed previous results of the ozonation of some 
of these compounds in ultrapure water at a much higher concentration [33-35]. It 
should be highlighted; however, that total removal means that pharmaceuticals were 
in water at concentrations below their detection limit of the HPLC method applied 
that was about 2 µg L
-1
. Thus, in Figures 6a,b,c results of the ozone processes 
studied here are shown. As can be seen these figures show, as examples, the changes 
observed with time of the concentrations of three out of seven pharmaceuticals still 
present in the urban wastewater after a 7 hours biological treatment period. These 
compounds are antipyrine, hydrochlorothiazide and ketorolac. The other 4 
compounds show similar results and removal rates. As can be seen from Figures 6 
pharmaceuticals compounds are eliminated in less than 10 minutes, regardless of the 
ozone process applied. On the contrary to the results observed with the 
pharmaceutical compounds, global parameters that measure the organic content or 
the presence of unsaturated groups (benzene rings, carbon double bonds, etc) in the 
biologically treated urban wastewater, that is, TOC or 254 nm absorbance show 
different results depending on the ozone process applied. Thus, Figure 7 depicts the 
time variation of percentage removal of TOC in the three ozone processes 
investigated. 
As it can be seen the single ozone process leads to about 13% TOC reduction after 
30 minutes treatment while about 32 and 36% TOC reductions are achieved with the 
Fe3O4 and Fe(III) photocatalytic ozonation processes, respectively. COD also 
showed similar results. 
In Figure 8, on the other hand, the time changes observed in the 254 nm absorption 
of treated samples is presented. As it can be observed, photocatalytic ozonation 
allowed higher percentage removal of unsaturated compounds than ozonation alone 
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(i.e. after 30 minutes reaction, 60 and 50% removal are achieved in the 
photocatalytic and non photocatalytic ozone processes, respectively). 
 
3.3. Ozone consumption 
 
For the ozonation processes investigated the consumption of ozone per TOC 
eliminated has also been determined following equation (1): 
 
  
 

3 3 3
3
0
· ·
( )·
O in O out O
O
t
m t m dt C V
TOC TOC V
  (1) 
where min and mout represent the ozone molar rates at the reactor inlet and outlet, 
respectively, CO3 the concentration of ozone dissolved in water, V the reactor 
volume, t the reaction time and TOC0 and TOCt values of TOC at the start of 
ozonation and at time t, respectively. Table 3 presents the results obtained.  
As it is observed from Table 3 photocatalytic ozonation processes consume lesser 
ozone amounts than the single ozonation process per mg of consumed TOC. This 
means that regarding the mineralization of organic compounds and economy to 
reduce the costs of ozone production, photocatalytic ozonation is a more 
economically selective process. 
 
3.4. Partial Oxidation Yield 
 
In order to quantitatively establish the oxidation capacity of the systems studied the 
partial oxidation yield, μpartox, was also calculated [36]. This parameter is defined as 
follows: 
  
0
100
partox
partox
COD
x
COD COD
  (2)  
where 
  0
0
partox
COD COD
COD TOC
TOC TOC
 
  
 
    (3) 
The partial oxidation yield indicates the percentage of COD removed that has not 
been mineralized. These parameters were also calculated for the biological process. 
Thus, for this first treatment the partial oxidation yield was 1.1% which means that 
98.9% of COD removed was mineralized. 
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For the ozone processes, results were as follows: In single ozonation 100% 
mineralization of the COD eliminated was achieved in 10 minutes. After this time no 
values can be considered since no further COD reductions were observed (see also 
Figure 7). In photocatalytic ozonation, regardless of the type of catalyst, percentage 
mineralization increases up to 85% of COD eliminated (35%) in the first 20 minutes. 
After this reaction time, remaining COD was unaltered as in the case of single 
ozonation. 
 
3.5. Oxidation State of Carbon 
 
The average oxidation state of carbon, AOSC, is another parameter, based on the 
measurements of TOC and COD. This parameter gives an estimation of the 
importance of oxygenated compounds present in water. It varies from -4 (that 
corresponds to organics such as methane) to +4 (that corresponds to organics such as 
carbon dioxide). In an oxidation process, regarding AOSC, what really matters is the 
increment observed in AOSC during the oxidation process, that is, [AOSC]. Both 
parameters are defined as follows [36]: 
 
 
12
4
32
TOC COD
ASOC
TOC
 
 
   (4) 
 
   0
0
12
4
32
COD COD
AOSC
TOC TOC
 
   
 
  (5) 
For the biological treatment, AOSC varies from -2 for the primary sedimentation 
wastewater (pharmaceuticals included) to +1 for the 7 hours biologically treated 
wastewater, that is, the increment of AOSC observed during the biological period 
([AOSC]) was 3. These results indicate that the biological treatment only lead to a 
partial state of oxidation of the remaining carbon.  
For the ozone processes the results were: For single ozonation no increment of 
oxidation state number was observed while for the photocatalytic ozone processes a 
0.3 increment was reached in 1 hour of reaction. However, it should be reminded 
that these parameters and also the partial oxidation yield have to be taken with 
caution since their values may also be due to the presence of inorganic substances 
that contribute to increase COD.  
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3.6. Biodegradability 
 
The ratio between BOD and COD is often defined as a measure of the 
biodegradability of the wastewater. Here, in this work this parameter has been 
measured at the start and end of the biological and chemical experiments. The results 
are shown in Table 4. 
As it can be seen from Table 4 a 50% increase of biodegradability is reached after 
the biological treatment while adding a further ozonation process leads to another 
100% increase as average. However, if biodegradability of non treated wastewater is 
compared to the one at the end of the sequence of biological plus chemical 
treatments, an average 200% increase of biodegradability is observed. 
 
3.7. Ecotoxicity 
 
For checking the toxicity of the raw wastewater and biological and chemically 
treated wastewaters, D. magna immobilisation tests were carried out. The results are 
shown in Table 5. An EC50 24 h of 1.88 mg L
-1
 was obtained for potassium 
dichromate, which is within range of the 0.6-2.1 mg L
-1
 stipulated in the ISO 6341 to 
ensure test validity. No swimming inhibition was observed in the controls exposed in 
each plate. As it can be seen from Table 5 only wastewater treated with Fe(III) 
photocatalytic ozonation results in a given degree of ecotoxicity. This could be 
attributed to the formation of the ferrioxalate complex during Fe(III) photocatalytic 
ozonation as deduced from Figure 9. Thus, Figure 9 presents the variation with time 
of total dissolved iron concentration during both ozone and ozone-free photocatalytic 
processes study in this work. As it can be seen from Figure 9 during Fe3O4 
photocatalytic runs, regardless of the presence of ozone, there is no iron leaching 
while during Fe(III) photocatalytic runs, the presence of ozone gives rise to a 
decrease of the dissolved iron concentration during the first 30 minutes undoubtedly 
due to the formation of ferryoxalate. Oxalic acid is a usual end product of ozonation 
runs [37-39] that has also been detected in this work. However, in the absence of 
ozone, no decrease of total iron concentration is observed which was due to the 
absence of oxalic acid formation during this run. Toxicity of ferryoxalate complex 
towards D. magna was reported by Trovó et al. [40,41] when they observed this 
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phenomenon during the photo-Fenton oxidation of amoxiciline and paracetamol 
(acetaminophen) with FeSO4 and potassium ferryoxalate as catalysts. These authors 
reported 100% D. magna mobility inhibition in a control run where ferryoxalate was 
present.  
  
3.8. Kinetic aspects 
 
As it can be deduced from this work, ozone-free photocatalytic oxidation processes 
require reaction times longer than 1 hour to observe some significant degradation of 
compounds and TOC. Ozone processes, on the other hand, are complex gas-liquid 
systems involving series-parallel reactions in water, and the kinetics depends on both 
ozone mass transfer and chemical reactions [42]. In order to establish the 
corresponding reaction rate expression, it is first necessary to know the kinetic 
regime where these reactions develop, that is, basically to know if the reactions are 
slow or fast compared to mass transfer rates. For so doing, the Hatta number of these 
reactions has to be determined. The Hatta number, Ha, of a second order gas-liquid 
reaction, as the ones ozone undergo in water, between ozone and a compound M, is 
defined as follows: 
 
3D O M
L
k D C
Ha
k
 
  (6) 
where kD, DO3, CM and kL are the rate constant of the reaction between ozone and 
compound M, the ozone diffusivity in water, the concentration of compound M and 
the liquid phase mass transfer coefficient, respectively. Table 6 shows the values of 
Ha corresponding to the ozone-pharmaceutical reactions at the conditions of the start 
of ozone processes, that is, with values of CM corresponding to those of the 
pharmaceuticals after the biological treatment. It should be noted that due to the lack 
of data found in literature on rate constants of direct ozone reactions at pH 3 most of 
Ha values have been determined with the rate constants at pH 7 and only a few of 
them at the pH of ozone reactions, that is, at pH 3. As it can be seen from Table 6, 
Ha shows values higher than 0.3 except for the cases of HCT and MET ozone 
reactions. According to gas-liquid reaction kinetic theory [48] this means that only 
the ozone-HCT and ozone- MET are slow reactions. In this case, as shown in a 
previous work [50] removal of HCT and MET can be due to the competitive 
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contributions of both their direct ozone reaction and hydroxyl radical reaction. Thus, 
in a semibatch well agitated reactor, as in this work, the mass balance of HCT and 
MET can be expressed as follows: 
 3
M
D O M HO OH M
dC
k C C k C C
dt
    (7) 
where CM and CO3 are the concentrations of HCT or MET and dissolved ozone in 
water, respectively, and kHO is the the rate constant of the reaction of hydroxyl 
radicals and the pharmaceutical compound. For the rest of pharmaceuticals, 
however, both ozone direct reaction and mass transfer through the liquid film close 
to the gas-liquid interphase simultaneously develop so that equation (7) does not 
hold. Accordingly, if pharmaceuticals can be removed in the ozone processes 
through both direct and hydroxyl radical reactions [42] (case of MET and HCT) the 
application of an ozone involving AOP is, a priori, advisable to improve their 
removal from water. For these two pharmaceuticals, the percentage contribution of 
the direct ozone reaction (%DR) for their removal has been calculated with the aid of 
equation (8): 
 3% 100D O M
M
k C C
DC x
dC
dt


 (8) 
Table 7 shows the values of %DC corresponding to the removal of MET and HCT. 
As it can be seen, HCT is mainly removed by hydroxyl radical oxidation regardless 
of the ozone process while some contribution of the direct ozone reaction is observed 
for the case of MET. In any case, the increase of reaction time leads to an increase of 
the contribution of the direct ozone reaction. For example, in the ozone process, after 
10 minutes, remaining concentrations of MET and HCT are 30 and 17 g L-1 and 
contribution of the direct ozone reaction was 35.9 and 12.7%, respectively. Similar 
trends are observed for photocatalytic ozone oxidations. According to these results 
some prediction can be made on the removal of the pharmaceuticals in ozone 
processes when present in actual wastewater at very low concentration (i.e. 200 ng L
-
1
). At this concentration, Hatta numbers of any ozone direct reaction are much lower 
than 0.3 (regardless of pH 3 or 7), that is, any ozone-pharmaceutical reaction is slow 
and equation (8) holds. Total accumulation rates (-dCM/dt) and dissolved ozone 
concentration are needed to apply equation (8). Predictions of these rates when the 
pharmaceutical concentration is very low can be made by assuming a pseudofirst 
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order kinetics for these processes. In fact, this assumption holds for the cases of HCT 
and MET ozonation. Thus, predicted pharmaceutical reaction rate would be: 
 'M M
dC
k C
dt
   (9) 
Least squares analysis of the logarithm of MET and HCT concentration with time 
gives the values of k’ shown in Table 8. As it can be observed, photocatalytic 
ozonation processes lead to higher k’ values than ozonation alone. However, the 
effect on compounds is different. Thus, Fe(III) seems to be more recommended to 
remove MET during photocatalytic ozonation than Fe3O4. The contrary situation is 
observed for HCT with magnetite as the most appropriate catalyst to improve the 
reaction rate. From theses k’ values, for a concentration of 200 ng L-1 accumulation 
rates, left term of equation (9), of MET and HCT were calculated. The dissolved 
ozone concentration is also needed to apply equation (8). For this concentration a 
value 10
-7
 M was assumed. This is a reasonable assumption for the start of the 
wastewater ozonation process since at 2 minutes ozonation a value of 5x10
-7
M was 
experimentally determined. With k’, kD, CO3 and CM the contribution of the direct 
reaction was then predicted from equation (8). Results are also shown in Table 8. It 
can be seen that also for very low pharmaceutical concentrations and regardless of 
the ozonation process type hydroxyl radical oxidation is the main way of 
pharmaceutical (HCT and MET) removal. Thus, application of an advanced 
oxidation process such as photocatalytic ozonation that increases the concentration 
of hydroxyl radicals is advisable. 
 
4. Conclusions 
 
From this work, the following conclusions can be derived: 
Aerobic biological oxidation of the utilized urban wastewater spiked with the nine 
pharmaceutical studied only completely removes AAF and CAF in 7 hours retention 
time. Most of compounds remain partially or completely refractory to the biological 
step.  
Application of any ozone processes removes the remaining pharmaceuticals in less 
than 10 minutes. 
Biodegradability of the treated wastewater increases both after the biological and 
chemical oxidation steps in 50% and 100%, respectively. Compared to the untreated 
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wastewater, a total increase of about 200% is observed after the sequence of 
treatments.  
After 30 minutes ozone process oxidation, Fe3O4 photocatalytic ozonation shows the 
lowest ozone consumption per TOC eliminated.   
Parameters measuring the oxidation improve of the wastewater (partial oxidation 
yield or oxidation state of carbon) also increase especially during the ozone 
processes.  
Ecotoxicity to Daphnia Magna resulted negative in all the cases except when Fe(III) 
was used as photocatalyst likely because of the formation of ferryoxalate. 
Application of gas-liquid reaction kinetic concepts to the ozone process results 
indicates that pharmaceuticals in urban wastewater, at low concentration (<g L-1) 
are removed from hydroxyl radicals instead of direct reactions. At hundreds of g L-
1
, however, some pharmaceuticals (SMT, DCF, ANT, KET) are mainly eliminated 
through their direct reactions with ozone. 
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